Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Deloitte
Cipla
Johnson and Johnson
Accenture
Daiichi Sankyo
Citi
US Army
Harvard Business School
AstraZeneca

Generated: February 19, 2018

DrugPatentWatch Database Preview

TROVAN Drug Profile

« Back to Dashboard

Which patents cover Trovan, and what generic alternatives are available?

Trovan is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-two drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.

US Patents and Regulatory Information for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-002 Dec 18, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-001 Dec 18, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer TROVAN/ZITHROMAX COMPLIANCE PAK azithromycin dihydrate; trovafloxacin mesylate FOR SUSPENSION, TABLET;ORAL 050762-001 Dec 18, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 ➤ Sign Up ➤ Sign Up
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ➤ Sign Up ➤ Sign Up
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 ➤ Sign Up ➤ Sign Up
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Mallinckrodt
Baxter
McKesson
Julphar
Moodys
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot